Krka DD (LTS:0HLK) FFO


LTS:0HLK Krka DD LTS:0HLK
84 GF Score
Price €64.80
GF Value €41.99
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Krka DD FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0HLK
84GF Score
Krka DD LTS:0HLK
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Krka DD (LTS:0HLK) Overvalued in 2026?

Based on GuruFocus' analysis, Krka DD stock appears to be overvalued. The current stock price of €64.80 is trading 54.3% above its estimated GF Value™ of €41.99. GuruFocus considers Krka DD to be Significantly Overvalued.

Key valuation signals for LTS:0HLK:

  • FFO:
  • GF Value™: €41.99 vs. price of €64.80 (54.3% above fair value)
  • GF Score™: 84/100 with 6 warning signs

No single metric tells the full story. See the LTS:0HLK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Krka DD Business Description

Address Smarjeska Cesta 6, Novo Mesto, SVN, 8501
Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resorts, and tourist services. The company's products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, and Oncology; Non-prescription products include Cold and cough products, nasal products, vitamins and minerals, and hair care products; and Animal health products include Antimicrobials and disinfectants, among others. It operates across the European Union, South-East Europe, Eastern Europe region, and Others. The company derives a majority of its revenue from the European Union.
84GF Score

Get the complete analysis for LTS:0HLK

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€64.80
Price
€41.99
GF Value